Journal of the Belgian Society of Radiology, 2022 Teaching Point: Spontaneous, atraumatic pneumocephalus is a rare presentation of pneumococcal meningitis.
Kelly Di Dier, Marc Lemmerling
europepmc +7 more sources
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project [PDF]
Microorganisms, 2021 Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project described the serotype distribution of remaining pneumococcal ...
Allison McGeer +2 more
exaly +5 more sources
Trends in Pneumococcal and Bacterial Meningitis in Brazil from 2007 to 2019
Vaccines, 2023 The pneumococcal conjugate vaccination (PCV) was introduced into the Brazilian Childhood National Immunization Program in 2010; however, universal pneumococcal vaccination for older adults has not been implemented yet.
Paula Batista +2 more
exaly +3 more sources
Epidemiology of pneumococcal meningitis in sentinel hospital surveillance of Viet Nam, 2015–2018 [PDF]
BMC Infectious DiseasesBackground Streptococcus pneumoniae (S. pneumoniae), Haemophilus influenzae (H. influenzae), and Neisseria meningitidis (N. meningitidis) are leading causes of childhood bacterial meningitis and preventable by vaccines.
Dac Trung Nguyen +20 more
doaj +2 more sources
Progranulin Plays a Protective Role in Pneumococcal Meningitis by Inhibiting Pyroptosis [PDF]
Immunity, Inflammation and DiseaseObjective Pneumococcal meningitis is a serious infectious disease with a high mortality rate and a global presence, and survivors have different degrees of neurological sequelae as a consequence of the host response to the infection.
Jingyao Wang +9 more
doaj +2 more sources
Long-Term Impact of Pneumococcal Conjugate Vaccines on the Burden of Pneumococcal Meningitis in Mozambique, 2013–2023 [PDF]
VaccinesBackground: Mozambique introduced the 10-valent pneumococcal conjugate vaccine (PCV10) in 2013 using a three-dose primary series with no booster dose (3p+0) and later switched to the PCV13 using a schedule of two primary doses with one booster (2p+1). We
Aquino Albino Nhantumbo +16 more
doaj +2 more sources
Journal of Infection and Public Health, 2017 This is a retrospective study to evaluate epidemiology and etiologies of childhood meningitis in Kuwait after the routine introduction of the pneumococcal conjugate vaccine. The data was collected from 196 patients in the period of 2010–2014.
Hussain Sadeq, Entesar H Husain
exaly +3 more sources
Effect of 10-valent pneumococcal conjugate vaccine on trends of pneumococcal meningitis in children under five years, Uganda, 2003–2022 [PDF]
BMC Infectious DiseasesBackground Pneumococcal meningitis, a vaccine-preventable disease caused by Streptococcus pneumoniae (Spn) is the leading bacterial meningitis in under five children.
Yasiini Nuwamanya +10 more
doaj +2 more sources
Estudi experimental del tractament de la meningitis pneumocòcica produïda per soques resistents a cefalosporines de tercera generació. Virulència, eficàcia i resposta inflamatòria [PDF]
, 2006 [cat] La meningitis pneumocòcica és una malaltia associada a una elevada mortalitat (20-40) i a l'aparició de seqüeles neurològiques en un 30% dels pacients, nens i adults, que sobreviuen.
Ribes Miravet, Sandra
core +6 more sources
Bioengineered Extracellular Vesicles Mitigate Neuroinflammation by Neutralizing Pneumolysin and Delaying Disease Onset in Experimental Pneumococcal Meningitis. [PDF]
J Extracell VesiclesABSTRACT Bacterial meningitis is a life‐threatening neurological disorder frequently caused by a Streptococcus pneumoniae (the pneumococcus) infection of the brain. Standard treatment consists of antibiotics to eliminate bacteria and dexamethasone to reduce inflammation.
Farmen K +9 more
europepmc +2 more sources